This pipeline uses various statistical tests to identify selected clinical features related to mutation rate.
Testing the association between 2 variables and 14 clinical features across 172 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 1 clinical feature related to at least one variables.
-
2 variables correlated to 'NUMBERPACKYEARSSMOKED'.
-
MUTATIONRATE_NONSYNONYMOUS , MUTATIONRATE_SILENT
-
No variables correlated to 'Time to Death', 'AGE', 'AGE_mutation.rate', 'NEOPLASM.DISEASESTAGE', 'PATHOLOGY.T.STAGE', 'PATHOLOGY.N.STAGE', 'PATHOLOGY.M.STAGE', 'GENDER', 'KARNOFSKY.PERFORMANCE.SCORE', 'HISTOLOGICAL.TYPE', 'RADIATIONS.RADIATION.REGIMENINDICATION', 'COMPLETENESS.OF.RESECTION', and 'RACE'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of variables that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.
| Clinical feature | Statistical test | Significant variables | Associated with | Associated with | ||
|---|---|---|---|---|---|---|
| Time to Death | Cox regression test | N=0 | ||||
| AGE | Spearman correlation test | N=0 | ||||
| AGE | Linear Regression Analysis | N=0 | ||||
| NEOPLASM DISEASESTAGE | Kruskal-Wallis test | N=0 | ||||
| PATHOLOGY T STAGE | Spearman correlation test | N=0 | ||||
| PATHOLOGY N STAGE | Spearman correlation test | N=0 | ||||
| PATHOLOGY M STAGE | Kruskal-Wallis test | N=0 | ||||
| GENDER | Wilcoxon test | N=0 | ||||
| KARNOFSKY PERFORMANCE SCORE | Spearman correlation test | N=0 | ||||
| HISTOLOGICAL TYPE | Kruskal-Wallis test | N=0 | ||||
| RADIATIONS RADIATION REGIMENINDICATION | Wilcoxon test | N=0 | ||||
| NUMBERPACKYEARSSMOKED | Spearman correlation test | N=2 | higher numberpackyearssmoked | N=2 | lower numberpackyearssmoked | N=0 |
| COMPLETENESS OF RESECTION | Kruskal-Wallis test | N=0 | ||||
| RACE | Kruskal-Wallis test | N=0 |
Table S1. Basic characteristics of clinical feature: 'Time to Death'
| Time to Death | Duration (Years) | 2-2370 (median=735.5) |
| censored | N = 100 | |
| death | N = 38 | |
| Significant variables | N = 0 |
Table S2. Basic characteristics of clinical feature: 'AGE'
| AGE | Mean (SD) | 65.43 (10) |
| Significant variables | N = 0 |
Table S3. Basic characteristics of clinical feature: 'AGE'
| AGE | Mean (SD) | 65.43 (10) |
| Significant variables | N = 0 |
Table S4. Basic characteristics of clinical feature: 'NEOPLASM.DISEASESTAGE'
| NEOPLASM.DISEASESTAGE | Labels | N |
| STAGE IA | 37 | |
| STAGE IB | 53 | |
| STAGE IIA | 11 | |
| STAGE IIB | 23 | |
| STAGE IIIA | 33 | |
| STAGE IIIB | 6 | |
| STAGE IV | 9 | |
| Significant variables | N = 0 |
Table S5. Basic characteristics of clinical feature: 'PATHOLOGY.T.STAGE'
| PATHOLOGY.T.STAGE | Mean (SD) | 1.94 (0.71) |
| N | ||
| 1 | 41 | |
| 2 | 109 | |
| 3 | 14 | |
| 4 | 8 | |
| Significant variables | N = 0 |
Table S6. Basic characteristics of clinical feature: 'PATHOLOGY.N.STAGE'
| PATHOLOGY.N.STAGE | Mean (SD) | 0.65 (0.82) |
| N | ||
| 0 | 95 | |
| 1 | 37 | |
| 2 | 34 | |
| 3 | 1 | |
| Significant variables | N = 0 |
Table S7. Basic characteristics of clinical feature: 'PATHOLOGY.M.STAGE'
| PATHOLOGY.M.STAGE | Labels | N |
| M0 | 143 | |
| M1 | 9 | |
| MX | 18 | |
| Significant variables | N = 0 |
Table S8. Basic characteristics of clinical feature: 'GENDER'
| GENDER | Labels | N |
| FEMALE | 93 | |
| MALE | 79 | |
| Significant variables | N = 0 |
No variable related to 'KARNOFSKY.PERFORMANCE.SCORE'.
Table S9. Basic characteristics of clinical feature: 'KARNOFSKY.PERFORMANCE.SCORE'
| KARNOFSKY.PERFORMANCE.SCORE | Mean (SD) | 65 (41) |
| Significant variables | N = 0 |
Table S10. Basic characteristics of clinical feature: 'HISTOLOGICAL.TYPE'
| HISTOLOGICAL.TYPE | Labels | N |
| LUNG ACINAR ADENOCARCINOMA | 2 | |
| LUNG ADENOCARCINOMA MIXED SUBTYPE | 39 | |
| LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS) | 115 | |
| LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS | 1 | |
| LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS | 2 | |
| LUNG CLEAR CELL ADENOCARCINOMA | 2 | |
| LUNG MICROPAPILLARY ADENOCARCINOMA | 2 | |
| LUNG MUCINOUS ADENOCARCINOMA | 2 | |
| LUNG PAPILLARY ADENOCARCINOMA | 4 | |
| LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA | 1 | |
| MUCINOUS (COLLOID) CARCINOMA | 2 | |
| Significant variables | N = 0 |
No variable related to 'RADIATIONS.RADIATION.REGIMENINDICATION'.
Table S11. Basic characteristics of clinical feature: 'RADIATIONS.RADIATION.REGIMENINDICATION'
| RADIATIONS.RADIATION.REGIMENINDICATION | Labels | N |
| NO | 15 | |
| YES | 157 | |
| Significant variables | N = 0 |
Table S12. Basic characteristics of clinical feature: 'NUMBERPACKYEARSSMOKED'
| NUMBERPACKYEARSSMOKED | Mean (SD) | 40.7 (25) |
| Significant variables | N = 2 | |
| pos. correlated | 2 | |
| neg. correlated | 0 |
Table S13. Get Full Table List of 2 variables significantly correlated to 'NUMBERPACKYEARSSMOKED' by Spearman correlation test
| SpearmanCorr | corrP | Q | |
|---|---|---|---|
| MUTATIONRATE_NONSYNONYMOUS | 0.2184 | 0.02071 | 0.0414 |
| MUTATIONRATE_SILENT | 0.1878 | 0.04738 | 0.0474 |
No variable related to 'COMPLETENESS.OF.RESECTION'.
Table S14. Basic characteristics of clinical feature: 'COMPLETENESS.OF.RESECTION'
| COMPLETENESS.OF.RESECTION | Labels | N |
| R0 | 115 | |
| R1 | 6 | |
| R2 | 4 | |
| RX | 9 | |
| Significant variables | N = 0 |
-
Expresson data file = LUAD-TP.patients.counts_and_rates.txt
-
Clinical data file = LUAD-TP.merged_data.txt
-
Number of patients = 172
-
Number of variables = 2
-
Number of clinical features = 14
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R
For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.